文献速递慢性肾脏病血液净化与透析遗传性与小管间质肾病

不明病因成人血液透析患者的基因诊断

Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology.
PubMed 文献 · Kidney Int Rep · 2024-02-14

这项多中心横断面队列研究对90例不明病因的成人血液透析患者进行298个CKD相关基因的靶向测序,发现10例(11.1%)携带致病性变异,17例(18.9%)携带意义不明变异,检出了PKD1、COL4A4、C3/CFHR5、COL4A3、NPHP1、GLA及UMOD等基因变异,提示存在未被诊断的遗传性肾病。

要点

  • 不明病因的成人透析患者中11.1%可检出CKD致病基因变异。
  • 基因诊断常与临床诊断不一致,仅PKD1变异者相符。
  • 靶向测序可揭示aHUS、Alport综合征等未诊断遗传病。

核心结论

  • 在不明病因的成人血液透析患者中存在未被诊断的遗传性肾脏病。

研究设计与样本

  • 多中心横断面队列研究,从4家日本透析诊所的1164例患者中筛选20-49岁开始肾脏替代治疗者。
  • 排除明显病因后纳入90例不明病因CKD患者,采用基于捕获的靶向二代测序分析298个CKD相关基因。

主要发现

  • 90例中10例(11.1%)携带CKD致病基因致病性变异,17例(18.9%)携带意义不明变异。
  • 3例携带PKD1致病性变异,1例同时携带PKD1和COL4A4致病性变异。
  • 2例因C3或CFHR5变异被诊断为非典型溶血性尿毒症综合征(aHUS)。
  • 各1例分别因COL4A4和COL4A3变异诊断为Alport综合征、因NPHP1变异诊断为肾单位肾痨、因GLA变异诊断为Fabry病、因UMOD变异诊断为常染色体显性肾小管间质性肾病。
  • 除PKD1变异患者外,基因诊断与临床诊断不一致。

临床怎么用

  • 对不明病因的成人透析患者可考虑CKD基因panel检测以明确遗传病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Kidney disease of unknown etiology accounts for 1 in 10 adult end-stage renal disease (ESRD) cases worldwide. The aim of this study is to clarify the genetic background of patients with chronic kidney disease (CKD) of unknown etiology who initiated renal replacement therapy (RRT) in adulthood. METHODS: This is a multicenter cross-sectional cohort study. Of the 1164 patients who attended 4 dialysis clinics in Japan, we first selected patients who started RRT between the ages of 20 and 49 years. After excluding patients with apparent causes of CKD (e.g., diabetic nephropathy, polycystic kidney disease (PKD) with family history, patients who underwent renal biopsy), 90 patients with CKD of unknown cause were included. The 298 genes associated with CKD were analyzed using capture-based targeted next-generation sequencing. RESULTS: Of the 90 patients, 10 (11.1%) had pathogenic variants in CKD-causing genes and 17 (18.9%) had variant of unknown significance (VUS). Three patients had PKD1 pathogenic variants, and 1 patient had PKD1 and COL4A4 pathogenic variants. In addition, 2 patients were diagnosed with atypical hemolytic uremic syndrome (aHUS) due to C3 or CFHR5. One patient each was diagnosed with Alport syndrome due to COL4A4 and COL4A3 variants, nephronophthisis due to NPHP1 variants, Fabry disease due to GLA variants, and autosomal-dominant tubulointerstitial kidney disease due to UMOD variants. Genetic diagnoses were not concordant with clinical diagnoses, except for patients with PKD1 variant. CONCLUSION: This largest study on genetic analysis in hemodialysis-dependent adults revealed the presence of undiagnosed inherited kidney diseases.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Fujimaru T, Mori T, Chiga M, et al. Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology. Kidney Int Rep. 2024. PMID: 38765603. doi:10.1016/j.ekir.2024.01.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。